
In this week’s Pharma Pulse, Lilly brings Zepbound and Foundayo to Hims & Hers, Swisslog Healthcare expands its Tenutō cold storage line, and FDA adds a NAION warning across the GLP-1 class.
Optimizing the use of data and improving the patient experience go hand in hand
Ushank Agarwal, vice president of commercial operations at HUTCHMED, a company developing targeted therapies for cancer and immunological diseases, talks about the importance of monitoring the patient journey in the complex and rare diseases space, and how to get the best out of data in this area.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.

